Ann N Morrison, NP
Nurse Practitioner · Pittsburgh
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 19 years
- Graduated 2007
Offices
1 location · P.K. Mullick, MD and Associates PC · 7 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Ann N Morrison’s office at (412) 621-4757 to ask if they take your plan before you enroll.
California Medical Board record
Licence C18154 · Deceased
Licence status: Deceased · since 1956 · University of Michigan Medical School.
Licensee is deceased.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$20,721
Pharmacies billed $20,721 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 208) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
195 generic and 13 brand-name prescriptions · $20,721 in drug cost · 13 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Duloxetine | 25 | $267 | $11 |
| Buspirone | 24 | $154 | $6 |
| Trazodone | 12 | $127 | $11 |
| Fluoxetine | 11 | $54 | $5 |
Money from drug and device companies
$575 in 2025
| 2025 | 7 | 25 | None | $575 |
| 2024 | 4 | 10 | None | $217 |
| 2023 | 1 | 1 | None | $15 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $211 | 7 payments
|
| Abbvie | Vraylar | $175 | 10 payments
|
| Otsuka America Pharmaceutical | Rexulti | $81 | 3 payments
|
| Janssen Pharmaceuticals | Invega Sustenna | $56 | 2 payments
|
| Alkermes | Aristada | $18 | 1 payment
|
| Vanda Pharmaceuticals | Fanapt | $18 | 1 payment
|
See all 25 published payments
| Abbvie | Meals · 2025-11-25 | Vraylar | $31 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-20 | Caplyta | $6 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-18 | Caplyta | $28 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-11-13 | Caplyta | $7 |
| Janssen Pharmaceuticals | Meals · 2025-10-30 | Invega Sustenna | $32 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-20 | Caplyta | $121 |
| Abbvie | Meals · 2025-09-16 | Vraylar | $17 |
| Abbvie | Meals · 2025-08-22 | Vraylar | $9 |
| Abbvie | Meals · 2025-08-12 | Vraylar | $11 |
| Abbvie | Meals · 2025-07-29 | Vraylar | $19 |
| Abbvie | Meals · 2025-07-10 | Vraylar | $29 |
| Abbvie | Meals · 2025-06-25 | Vraylar | $11 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-24 | Caplyta | $10 |
| Abbvie | Meals · 2025-06-11 | Vraylar | $19 |
| Otsuka America Pharmaceutical | Meals · 2025-06-04 | Rexulti | $26 |
| Otsuka America Pharmaceutical | Meals · 2025-05-13 | Rexulti | $27 |
| Abbvie | Meals · 2025-05-07 | Vraylar | $18 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-29 | Caplyta | $20 |
| Abbvie | Meals · 2025-04-28 | Vraylar | $12 |
| Janssen Pharmaceuticals | Meals · 2025-04-15 | Invega Sustenna | $24 |
| Lundbeck | Meals · 2025-02-25 | Rexulti | $17 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-18 | Caplyta | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-02-11 | Rexulti | $28 |
| Vanda Pharmaceuticals | Meals · 2025-02-05 | Fanapt | $18 |
| Alkermes | Meals · 2025-01-15 | Aristada | $18 |
See earlier years (2024, 2023)
2024: $217
| Otsuka America Pharmaceutical | Abilify Maintena | $150 | 7 payments
|
| Alkermes | Lybalvi | $31 | 1 payment
|
| Lundbeck | Rexulti | $19 | 1 payment
|
| Teva Pharmaceuticals USA | Uzedy | $17 | 1 payment
|
2023: $15
| Janssen Pharmaceuticals | Spravato | $15 | 1 payment
|
Professional record
- NPI
- 1740436492
- Licence
- CA 18154California C18154: Deceased
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X); Federal specialty code 172V00000X (172V00000X)
- Mailing address
- 730 Welch Rd, Mail Code 5886, Palo Alto, CA, 94304
- NPI first listed
- 2008-08-13
- NPI last updated
- 2010-04-16
This is when the NPI record was last certified, not a medical board exam.